Project Grant HT94252410687
Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
- This federal Project Grant award, valued at $538,998.00 and provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), aims to enhance the antitumor myeloid immune response for the treatment of adrenocortical carcinoma. The award was made to the University of Utah's Office of Sponsored Projects Division, a major recipient of federal funding that conducts cutting-edge biomedical research. The funding will support a research project focused...
- The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
- The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
- The U.S. Department of Defense's Defense Health Agency awarded a $395,202 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "PET IMAGING OF HIF 2A IN RENAL CANCER," supports research to develop new imaging techniques for detecting and monitoring kidney cancer in military personnel and veterans. The three-year award, running from September 1, 2023 to August...
- Federal Project Grant Award Summary The University of Utah's Office of Sponsored Projects received a $1,395,804 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. The award funds investigator-initiated research on exposure-induced lung injury and interventions to prevent early lung cancer progression, addressing health outcomes relevant to Service Members and the...
- The Defense Health Agency awarded the University of Utah a $559,972 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2028. The project, titled "Preventing Melanoma Metastatic Spread with Engineered Macrophages," supports investigator-initiated biomedical research addressing Service Member health and medical innovation. This award reflects the program's portfolio of clinical and translational research...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,037,990 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420) to develop a safe small molecule approach to prevent kidney cancer metastasis. The three-year grant, which began on September 1, 2023, will support UCLA's research efforts to investigate new treatments for kidney cancer that could benefit military service members and the general...
- This federal Project Grant award for $968,904.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Texas Southwestern Medical Center (UT Southwestern) to target the DNA damage response as a potential treatment for clear cell renal cell carcinoma. The project will be conducted at UT Southwestern's facilities in Dallas, Texas over a 4-year period from July 1, 2024 to June 30, 2028. This...
- This $834,798 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports PET imaging research of HIF 2A in renal cancer at The University of Texas Southwestern Medical Center in Dallas, Texas. The research project aims to develop new diagnostic and treatment approaches for kidney cancer, which is a key focus area for this Defense Department program. The award will fund basic, translational, and clinical research...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $999,096.00 to The University of Texas Southwestern Medical Center to conduct research on "Targeting DNA Damage Response to Treat Clear Cell Renal Cell Carcinoma." The award period runs from July 1, 2024 to June 30, 2028. The research aims to develop new treatments for clear cell renal cell carcinoma, a type of kidney cancer, by investigating...